Literature DB >> 27725130

Lack of Toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance.

Martin Böhland1, Eugenia Kress1, Matthias B Stope2, Thomas Pufe1, Simone C Tauber3, Lars-Ove Brandenburg4.   

Abstract

Bacterial meningitis is - despite therapeutical progress during the last decades - still characterized by high mortality and severe permanent neurogical sequelae. The brain is protected from penetrating pathogens by both the blood-brain barrier and the innate immune system. Invading pathogens are recognized by so-called pattern recognition receptors including the Toll-like receptors (TLR) which are expressed by glial immune cells in the central nervous system. Among these, TLR2 is responsible for the detection of Gram-positive bacteria such as the meningitis-causing pathogen Streptococcus pneumoniae. Here, we used TLR2-deficient mice to investigate the effects on mortality, bacterial growth and inflammation in a mouse model of pneumococcal meningitis. Our results revealed a significantly increased mortality rate and higher bacterial burden in TLR2-deficient mice with pneumococcal meningitis. Furthermore, infected TLR2-deficient mice suffered from a significantly increased pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) and Chemokine (C-C motif) ligand 2 (CCL2) or CCL3 chemokine expression and decreased expression of anti-inflammatory cytokines and antimicrobial peptides. In contrast, glial cell activation assessed by glial cell marker expression was comparable to wildtype mice. Taken together, the results suggest that TLR2 is essential for an efficient immune response against Streptococcus pneumoniae meningitis since lack of the receptor led to a worse outcome by higher mortality due to increased bacterial burden, weakened innate immune response and reduced expression of antimicrobial peptides.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Bacterial meningitis; Glia cell; Innate immunity; Streptococcus pneumoniae; Toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 27725130     DOI: 10.1016/j.jneuroim.2016.09.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

2.  Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.

Authors:  Kari Ann Shirey; Darren J Perkins; Wendy Lai; Wei Zhang; Lurds R Fernando; Fabian Gusovsky; Jorge C G Blanco; Stefanie N Vogel
Journal:  mBio       Date:  2019-05-07       Impact factor: 7.867

3.  Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis.

Authors:  Lay Khoon Too; Belinda Yau; Alan G Baxter; Iain S McGregor; Nicholas H Hunt
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

4.  Genetic influence of Toll-like receptors on non-HIV cryptococcal meningitis: An observational cohort study.

Authors:  Ying-Kui Jiang; Ji-Qin Wu; Hua-Zhen Zhao; Xuan Wang; Rui-Ying Wang; Ling-Hong Zhou; Ching-Wan Yip; Li-Ping Huang; Jia-Hui Cheng; Ya-Hong Chen; Hua Li; Li-Ping Zhu; Xin-Hua Weng
Journal:  EBioMedicine       Date:  2018-10-23       Impact factor: 8.143

5.  Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.

Authors:  Agata Famà; Angelina Midiri; Giuseppe Mancuso; Carmelo Biondo; Germana Lentini; Roberta Galbo; Maria Miriam Giardina; Giuseppe Valerio De Gaetano; Letizia Romeo; Giuseppe Teti; Concetta Beninati
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.